Timo Minssen
Professor
JUR Center for Advanced Studies in Bioscience Innovation Law
Karen Blixens Plads 16
2300 København S
- Lecture and oral contribution
The CoNeXT project: Legal challenges in interdisciplinary settings, Danish Young Academy of Sciences
Yu, H. (Speaker), Wested, Jakob (Speaker) & Minssen, Timo (Panel member)
1 Nov 2017Activity: Talk or presentation types › Lecture and oral contribution
The Collaborative Research Programme in Biomedical Innovation Law (CeBIL)- Past, Presence & Future Visions
Minssen, Timo (Invited speaker)
9 Nov 2017Activity: Talk or presentation types › Lecture and oral contribution
The EPO’s plausibility approach and the industrial application requirement in biotech patenting
Minssen, Timo (Lecturer)
13 Aug 2012Activity: Talk or presentation types › Lecture and oral contribution
The European assessment of "inventive step"
Minssen, Timo (Speaker)
7 Feb 2015 → 11 Feb 2015Activity: Talk or presentation types › Lecture and oral contribution
The Importance of Social Sciences for a One Health Approach to Antimicrobial Resistance
Minssen, Timo (Other)
18 Aug 2020Activity: Talk or presentation types › Lecture and oral contribution
The Patent Governance of Genome Editing Technologies
Minssen, Timo (Other)
9 Jun 2022Activity: Talk or presentation types › Lecture and oral contribution
The Patent-Eligibility of Dosage Regimes and Diagnostic Methods in the U.S. & Europe
Minssen, Timo (Speaker)
13 Sep 2011Activity: Talk or presentation types › Lecture and oral contribution
The Proposed EU IP Exception for Generics & Biosimilars Exports - A Cure Worse Than the Disease? (at UC Irvine)
Minssen, Timo (Invited speaker)
8 Feb 2019Activity: Talk or presentation types › Lecture and oral contribution
The Scope of Protection for Biotech-Patents after Monsanto v. Cefetra
Minssen, Timo (Speaker)
8 Nov 2011Activity: Talk or presentation types › Lecture and oral contribution
The UPCA’s ”opt out” and “opt-in” provisions - Impact and strategies for European patent portfolios.
Minssen, Timo (Lecturer)
7 Oct 2014Activity: Talk or presentation types › Lecture and oral contribution
The US Supreme Court in FTC v. Actavis - Context, outcome & implications
Minssen, Timo (Lecturer)
18 Jun 2013Activity: Talk or presentation types › Lecture and oral contribution
The industrial application requirement for biotech inventions in light of recent EPO & UK case law: A plausible "hunting license"?
Minssen, Timo (Lecturer)
12 Aug 2013Activity: Talk or presentation types › Lecture and oral contribution
The legal dimension of large European Research Infrastructures and the CoNext project
Minssen, Timo (Speaker)
31 Oct 2014Activity: Talk or presentation types › Lecture and oral contribution
The legal dimensions of Big Data: University of Copenhagen
Minssen, Timo (Lecturer)
20 May 2016Activity: Talk or presentation types › Lecture and oral contribution
The legal ecology of resistance, or why normal IP rules should not apply to antibiotics- An IP seminar at the University of Oxford
Minssen, Timo (Speaker)
25 Apr 2014Activity: Talk or presentation types › Lecture and oral contribution
The legal method of "Law & Technology"
Minssen, Timo (Lecturer)
6 Jun 2013Activity: Talk or presentation types › Lecture and oral contribution
The massive Impact of Brexit on Danish & UK life science corporations & collaborations
Minssen, Timo (Invited speaker) & Bostyn, Sven (Invited speaker)
10 Dec 2018Activity: Talk or presentation types › Lecture and oral contribution
The new Centre for Advanced Studies in Biomedical Innovation Law (CeBIL): Where we come from - What we do - Where we want to go.
Minssen, Timo (Speaker) & Wested, Jakob (Speaker)
25 May 2018Activity: Talk or presentation types › Lecture and oral contribution
The patent eligibility of human embryonic stem cell technology in Europe
Minssen, Timo (Lecturer)
13 Aug 2012Activity: Talk or presentation types › Lecture and oral contribution
The patent eligibility of human embryonic stem cell technology in Europe - What happened after Brüstle?
Minssen, Timo (Lecturer)
12 Aug 2013Activity: Talk or presentation types › Lecture and oral contribution
The patentability of personalized medicine in Europe - Dosage regimes and genetic diagnostic methods
Minssen, Timo (Lecturer)
13 Aug 2012Activity: Talk or presentation types › Lecture and oral contribution
U.S. regulation and patentability of human embryonic stem cell research
Minssen, Timo (Speaker)
21 Mar 2012Activity: Talk or presentation types › Lecture and oral contribution
US decisions in Sequenom Inc v Ariosa Diagnostics Inc- What now?: University of Cambridge (UK)
Minssen, Timo (Invited speaker)
6 Sep 2016Activity: Talk or presentation types › Lecture and oral contribution
Utility Model Protection in Danish Law at LSE
Minssen, Timo (Other)
2 Feb 2023Activity: Talk or presentation types › Lecture and oral contribution
WHO panel on the governance of gene editing
Minssen, Timo (Other)
2021Activity: Talk or presentation types › Lecture and oral contribution
ID: 16150437
Most downloads
-
4325
downloads
När anses en bioteknologisk uppfinning vara komplett och praktiskt användbar? – Del 1: – Om nyare utvecklingar kring kravet på ’industrial application’ och ’utility’ för gen- och proteinrelaterade uppfinningar i USA och Europa
Research output: Contribution to journal › Journal article › peer-review
Published -
2171
downloads
The Evolution of the CJEU’s Case Law on Stem Cell Patents: Context, Outcome and Implications of Case C‑364/13 International Stem Cell Corporation.
Research output: Contribution to journal › Journal article › peer-review
Published -
2073
downloads
När anses en bioteknologisk uppfinning vara komplett och praktiskt användbar? – Del 2: Om nyare utvecklingar kring kravet på ’industrial application’ och ’utility’ för gen- och proteinrelaterade uppfinningar i USA och Europa
Research output: Contribution to journal › Journal article › peer-review
Published